NYSE · traded in Congress
AbbVie ABBV
$264.70 -0.42 (-0.16%) Sep 25, 2026 5:01 AM ET
Market value$467.8B
P/E ratio-
Analyst target$281.00
52-week range-
Avg volume7,233,543
Dividend yield-
Chart
Congress trades in ABBV
Members of Congress disclosed 2 transactions in ABBV in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/14/2026 | Pete Sessions TX17 | Sale | $15,001 - $50,000 | 9/18/2026 filing |
| 05/05/2026 | Josh Gottheimer NJ05 | Sale | $1,001 - $15,000 | 6/3/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Our coverage
- ADARx prices upsized IPO at $17 to raise $446 million; AbbVie's side purchase works out to about $89 million Stocks · September 25, 2026
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.